[Featured Stock] Daebong LS Soars 21.83% on Announcement of Free Capital Increase
![[Featured Stock] Daebong LS Soars 21.83% on Announcement of Free Capital Increase](http://www.asiae.co.kr/news/img_view.htm?img=2022071210592646439_1657591166.jpg)
[Asia Economy Reporter Hwang Junho] Daebong LS is surging on news of a free capital increase by its subsidiary, P&K Skin Clinical Research Center.
As of 10:14 AM on the 12th, Daebong LS is trading at 8,790 KRW, up 16.27% from the previous day.
On the same morning, P&K Skin Clinical Research Center announced a decision to issue three free shares for every one common share. Trading of this stock was suspended for 30 minutes from the time of the announcement due to the disclosure of major matters.
Hot Picks Today
!["I Got Hired but Can't Use a Keyboard"... The Challenge Making Gen Z New Hires Sweat [The World is Z-Gold]](https://cwcontent.asiae.co.kr/asiaresize/93/2026100113552847569_1790830528.png)
"I Got Hired but Can't Use a Keyboard"... The Challenge Making Gen Z New Hires Sweat [The World is Z-Gold]
- "Turning a Fatal Shooting Into Merchandise"... Controversy Over 'Assassin(s)' Megabox Ticket
- "Oh Se-hoon Doesn't Know"… The Weight of the Recording Ahead of the Appellate Verdict
- "Who Knew Yesterday’s Photo Would Be the Last"...550-Year-Old Hawaiian Landmark Disappears Overnight
- Shark "Bukangyi" Jumps Over 7m Net and Returns Inside the Canal
Daebong LS is the largest shareholder, holding 54.74% of P&K Skin Clinical Research Center's shares.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
